companies selecta-biosciences-inc 
Benzinga
NOVEMBER 13, 2023
Selecta Biosciences Inc (NASDAQ: SELB ) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning 26.9% of the new company.
Benzinga
NOVEMBER 13, 2023
million from concurrent private financing; expected cash runway through Phase 3 development of Descartes-08 for MG – – Combined company to be led by Carsten Brunn, Ph.D.; million from concurrent private financing; expected cash runway through Phase 3 development of Descartes-08 for MG – – Combined company to be led by Carsten Brunn, Ph.D.;
Expert insights. Personalized for you.
59 
Let's personalize your content